A Multicenter, Open-label, Non-randomized Phase I/IIa Clinical Trial to Evaluate INR102 Injection in Patients With Prostate Cancer

Clinical trial NCT06970119 · RECRUITING

Trial details

NCT number: NCT06970119
Sponsor: Yunhe Pharmaceutical (Tianjin) Co., Ltd
Status: RECRUITING
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Prostate Cancer

Start date: 2025-05-14
Primary completion: 2029-06-20
Enrollment: 55

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.